Suda Pharmaceuticals Ltd Share Price Australian S.E.
Equities
SUD
AU0000063661
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- AUD | -.--% | -.--% | -.--% |
26/03 | Arovella Therapeutics Receives Firm Commitments for About AU$12.5 Million Raise | MT |
20/03 | Arovella Therapeutics' ALA-101-onCARlytics Collaboration with Imugene Ends; Shares Down 12% | MT |
Sales 2022 | 296K 192K 16.01M | Sales 2023 | 1.45M 944K 78.75M | Capitalization | 42.5M 27.57M 2.3B |
---|---|---|---|---|---|
Net income 2022 | -8M -5.19M -433M | Net income 2023 | -10M -6.49M -541M | EV / Sales 2022 | 32 x |
Net cash position 2022 | 5.93M 3.84M 321M | Net cash position 2023 | 5.18M 3.36M 280M | EV / Sales 2023 | 25.7 x |
P/E ratio 2022 |
-1.47
x | P/E ratio 2023 |
-3.49
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 91.45% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Baker
CEO | Chief Executive Officer | - | 02/20/02 |
Tim Luscombe
DFI | Director of Finance/CFO | - | 01/12 |
Michelle Long
ADM | Chief Administrative Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Phillips
BRD | Director/Board Member | 62 | 01/22/01 |
Elizabeth Stoner
BRD | Director/Board Member | 73 | 10/21/10 |
Thomas Duthy
CHM | Chairman | - | 13/23/13 |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.48% | 42.86B | |
+12.25% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+6.16% | 25.15B | |
-23.65% | 18.63B | |
+27.57% | 12.37B | |
-3.31% | 11.92B | |
+7.30% | 11.21B |
- Stock Market
- Equities
- ALA Stock
- SUD Stock